Recall of infant ibuprofen sold at Walmart, CVS expanded over dosage concerns
MONMOUTH JUNCTION, N.J. – A New Jersey-based pharmaceutical company has expanded a November 2018 recall of lots of liquid infant ibuprofen that might be more concentrated than advertised. Tris Pharma’s voluntary recall covers Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 ml. Three lots have been added to the original recall.